Facebook
Twitter
Telegram
Report an ErrorUroGen Pharma Ltd. Cash Flow 2011-2024 | URGN
Annual Cash Flow UroGen Pharma Ltd.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-76.4 M | -87.6 M | -84.9 M | -106 M | -71 M | -37.3 M | -9.57 M | 4.19 M | -7.18 M | - | - | - | - |
Depreciation & Amortization |
802 K | 924 K | 831 K | 416 K | 300 K | 400 K | 200 K | 200 K | 113 K | - | - | - | - |
Accounts Payables |
6.51 M | 5.53 M | 5.79 M | 3.27 M | 4.69 M | 4.27 M | - | - | - | - | - | - | - |
Accounts Receivables |
15.4 M | 12.7 M | 11.7 M | 7.05 M | - | - | - | - | - | - | - | - | - |
Total Inventories |
5.67 M | 4.32 M | 4.83 M | 1.96 M | - | - | 316 K | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow UroGen Pharma Ltd.
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-31.7 M | - | - | - | -25.8 M | - | -65.8 M | -48.2 M | -24 M | - | -64.8 M | -46.3 M | -27.4 M | - | -84.6 M | -59.6 M | -35.6 M | - | -45 M | -32.5 M | -17.9 M | - | -27 M | -17.8 M | -9.62 M | - | - | - | -2.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
123 K | - | 200 K | 200 K | 217 K | - | 200 K | 200 K | 215 K | - | 200 K | 200 K | 191 K | - | 100 K | 100 K | 100 K | - | 100 K | 100 K | 100 K | - | 100 K | 47.5 K | 200 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
6.26 M | 6.51 M | 4.04 M | 4.66 M | 6.97 M | 5.53 M | 2.54 M | 2.46 M | 4.23 M | 5.79 M | 4.06 M | 4.83 M | 6.1 M | 3.27 M | 3.27 M | 3.27 M | 3.27 M | 4.69 M | 4.69 M | 4.69 M | 4.69 M | 4.27 M | 4.27 M | 4.27 M | 4.27 M | 2.84 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
14.2 M | 15.4 M | 12.8 M | 15.5 M | 12.5 M | 12.7 M | 9.43 M | 11.6 M | 9.5 M | 11.7 M | 7.78 M | 9.51 M | 6.3 M | 7.05 M | 7.05 M | 7.05 M | 7.05 M | - | - | - | - | - | 112 K | 232 K | 4 K | - | - | - | - | 83 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
7.24 M | 5.67 M | 5 M | 4.99 M | 5.47 M | 4.32 M | 4.86 M | 5.05 M | 4.76 M | 4.83 M | 3.81 M | 3.42 M | 3.33 M | 1.96 M | 1.96 M | 1.96 M | 1.96 M | - | - | - | - | - | - | 142 K | 349 K | 316 K | - | - | - | 105 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency